Atlas Trials

Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

Clinical trial NCT03675282 · COMPLETED

Trial details

NCT number
NCT03675282
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson DiseaseREM Sleep Behavior DisorderHealthy
Start date
2018-08-14
Primary completion
2024-04-23
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.